Home »
» Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds
November 09, 2022
https://ift.tt/auRNOvn
The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.
Source link
source
https://financetin.com/paxlovid-may-reduce-risk-of-long-covid-in-eligible-patients-study-finds/financetin.com
Related Posts:
Survivors' COVID Antibodies May Be a Powerful Gift
These antibodies are among the most potent against the SARS-CoV-2 virus, and could be produced by drug companies in large quantities, according to a team from Columbia University Irving Medical Center.
from WebMD Healthhtt… Read More- Cheryl Alters Jamison’s Spare Ribs Recipe Is a Barbecue EssentialCheryl Alters Jamison’s newest cookbook, Texas Q, serves up a smoked spare ribs recipe that will take your barbecue to the next level.
WITH NEARLY 270,000 square miles of undulating hills, sun-scorched savanna, rushing rivers… Read More
- Concussion Ups Odds for Many Brain Conditions
The study of more than 186,000 Canadians found that those who suffered a concussion were more likely to develop any of several conditions, including: attention-deficit/hyperactivity disorder (ADHD); depression or anxiety; Pa… Read More
- Teva and Cotopaxi Launch Sustainable, Limited-Edition CollaborationOn July 28, tried-and-true footwear company Teva and the adventure apparel brand Cotopaxi (famed for its playful use of color) announced an all-new collaboration. The sustainable line uses recycled materials to reimagine… Read More
- New Additions to the Goodyear Wingfoot Alliance: Joel Anderson and Conor MacfarlanePress Release: Goodyear Bicycle Tires
First launched in 2018 with official licensed partner, Rubber Kinetics, Goodyear’s brand presence continues to make an impact within the global cycling market. In support of the Goodyear … Read More
0 comments:
Post a Comment